Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Clinical trial NCT01495468 · COMPLETED

Trial details

NCT number: NCT01495468
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2007-03-01
Primary completion: 2008-01-01
Enrollment: 343

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.